Bruker (BRKR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

04.08.25 15:30 Uhr

Werte in diesem Artikel
Aktien

27,14 EUR 0,87 EUR 3,31%

70,00 EUR 0,00 EUR 0,00%

Bruker (BRKR) reported $797.4 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 0.4%. EPS of $0.32 for the same period compares to $0.52 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $796.5 million, representing a surprise of +0.11%. The company delivered an EPS surprise of -3.03%, with the consensus EPS estimate being $0.33.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Bruker performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Organic revenue growth - Total: -7% versus the three-analyst average estimate of -1.9%.Organic revenue growth - Bruker Scientific Instruments (BSI): -7.2% compared to the -2% average estimate based on two analysts.Organic revenue growth - Bruker Energy & Supercon Technologies (BEST): -4.8% versus -6.8% estimated by two analysts on average.Revenue- Eliminations: $-2.1 million versus the three-analyst average estimate of $-5.88 million. The reported number represents a year-over-year change of -47.5%.Revenue- Bruker Energy & Supercon Technologies (BEST): $66.3 million compared to the $67.51 million average estimate based on three analysts. The reported number represents a change of -4.1% year over year.View all Key Company Metrics for Bruker here>>>Shares of Bruker have returned -10.5% over the past month versus the Zacks S&P 500 composite's +0.6% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Zacks Names #1 Semiconductor StockThis under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bruker Corporation (BRKR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Bruker und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Bruker

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Bruker

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Bruker Corp

Wer­bung

Analysen zu Bruker Corp

DatumRatingAnalyst
24.06.2019Bruker Strong BuyNeedham & Company, LLC
30.05.2019Bruker Peer PerformWolfe Research
06.05.2019Bruker Strong BuyNeedham & Company, LLC
12.04.2019Bruker BuyDeutsche Bank AG
12.02.2019Bruker BuyBTIG Research
DatumRatingAnalyst
24.06.2019Bruker Strong BuyNeedham & Company, LLC
06.05.2019Bruker Strong BuyNeedham & Company, LLC
12.04.2019Bruker BuyDeutsche Bank AG
12.02.2019Bruker BuyBTIG Research
03.01.2019Bruker Strong BuyNeedham & Company, LLC
DatumRatingAnalyst
30.05.2019Bruker Peer PerformWolfe Research
18.01.2017Bruker HoldDeutsche Bank AG
04.01.2017Bruker Equal WeightBarclays Capital
05.05.2016Bruker NeutralMizuho
07.01.2016Bruker HoldDeutsche Bank AG
DatumRatingAnalyst
09.10.2018Bruker SellUBS AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Bruker Corp nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen